Sensirion H1 profit jumps on medical demand; lifts outlook
Sensirion H1 profit jumps on medical demand; lifts outlook
Overview
Switzerland digital microsensor maker's H1 revenue fell 3% yr/yr in CHF, up 6.9% in local currencies
Net income for H1 rose 82% to CHF 18.9 mln, driven by improved financial result
Company raised 2026 revenue forecast to CHF 345–365 mln, citing strong demand and positive trends
Outlook
Sensirion raises 2026 revenue forecast to CHF 345–365 mln from CHF 335–360 mln
Company expects 2026 revenue growth of 8% to 14% in local currencies
Sensirion now sees 2026 EBITDA margin in upper half of mid-to-high teens range
Result Drivers
MEDICAL DEMAND - Sensirion said high demand in the medical market, especially for CPAP and ventilation applications, contributed to H1 growth
CONSUMER SEGMENT - Strong growth in the consumer market driven by high demand in distribution business across all regions
EFFICIENCY AND PRICE ADJUSTMENTS - Efficiency improvements, targeted price adjustments and internationalization offset negative currency effects and rising material costs
Company press release: ID:nEQc2JV4ta
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue | Beat | CHF 179 mln | CHF 171 mln (1 Analyst) |
H1 EPS |
| CHF 1.21 |
|
H1 Net Income |
| CHF 18.90 mln |
|
H1 EBIT | Beat | CHF 23.90 mln | CHF 17 mln (1 Analyst) |
H1 EBITDA |
| CHF 34.90 mln |
|
H1 Gross Profit |
| CHF 94.10 mln |
|
H1 Operating Cash Flow |
| CHF 34 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the electronic equipment & parts peer group is "buy"
Wall Street's median 12-month price target for Sensirion Holding AG is CHF86.00, about 10.8% above its August 18 closing price of CHF77.60
The stock recently traded at 39 times the next 12-month earnings vs. a P/E of 35 three months ago
Reuters Recommended Reads
Aug 18 - Switzerland's Huber+Suhner H1 sales rise 2.6% EBIT falls on investments
Aug 18 - Switzerland's SKAN Group H1 net sales rise on Services & Consumables growth, acquisitions
Aug 18 - Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlook
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Sensirion Holding AG
See all newsEurope Research Roundup: ASM International, Michelin, Nokian Renkaat
Swiss stocks - Factors to watch on August 19
Sensirion H1 profit jumps on medical demand; lifts outlook
Brief: Sensirion Holding Raises 2026 Revenue Forecast To CHF 345–365 MLN
Switzerland's Sensirion beats 2025 revenue expectations on US market expansion